Edward E. Graves

9.8k total citations
174 papers, 7.2k citations indexed

About

Edward E. Graves is a scholar working on Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Radiation. According to data from OpenAlex, Edward E. Graves has authored 174 papers receiving a total of 7.2k indexed citations (citations by other indexed papers that have themselves been cited), including 85 papers in Radiology, Nuclear Medicine and Imaging, 66 papers in Pulmonary and Respiratory Medicine and 43 papers in Radiation. Recurrent topics in Edward E. Graves's work include Medical Imaging Techniques and Applications (49 papers), Advanced Radiotherapy Techniques (43 papers) and Cancer, Hypoxia, and Metabolism (25 papers). Edward E. Graves is often cited by papers focused on Medical Imaging Techniques and Applications (49 papers), Advanced Radiotherapy Techniques (43 papers) and Cancer, Hypoxia, and Metabolism (25 papers). Edward E. Graves collaborates with scholars based in United States, Canada and Australia. Edward E. Graves's co-authors include Ralph Weissleder, Vasilis Ntziachristos, Jorge Ripoll, Billy W. Loo, Quynh‐Thu Le, Marjan Rafat, Amato J. Giaccia, Sarah J. Nelson, Andrew Quon and Peter G. Maxim and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Nature Communications.

In The Last Decade

Edward E. Graves

171 papers receiving 7.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Edward E. Graves United States 45 3.2k 1.9k 1.6k 1.5k 1.3k 174 7.2k
Daniel Zips Germany 42 2.6k 0.8× 2.5k 1.3× 1.6k 1.0× 761 0.5× 1.8k 1.5× 310 6.9k
Johannes H.A.M. Kaanders Netherlands 50 2.3k 0.7× 2.2k 1.2× 1.9k 1.2× 634 0.4× 1.7k 1.4× 177 7.4k
Peter E. Huber Germany 59 2.4k 0.7× 3.1k 1.6× 3.0k 1.8× 1.7k 1.2× 3.0k 2.4× 265 11.5k
Albert J. van der Kogel Netherlands 53 2.6k 0.8× 2.1k 1.1× 2.4k 1.4× 762 0.5× 1.2k 0.9× 140 8.2k
Mechthild Krause Germany 49 2.4k 0.8× 3.5k 1.8× 2.5k 1.5× 863 0.6× 3.1k 2.5× 252 8.8k
Mark De Ridder Belgium 39 1.7k 0.5× 2.1k 1.1× 715 0.4× 592 0.4× 1.4k 1.1× 199 5.2k
Peter Peschke Germany 41 1.7k 0.5× 1.3k 0.7× 1.4k 0.8× 989 0.7× 657 0.5× 147 4.7k
Jason A. Koutcher United States 55 4.7k 1.5× 3.8k 2.0× 4.9k 3.0× 810 0.5× 2.3k 1.8× 233 13.0k
Michael Milosevic Canada 62 3.8k 1.2× 3.6k 1.9× 2.2k 1.4× 1.6k 1.1× 2.1k 1.7× 312 12.3k
Michael R. Horsman Denmark 55 2.8k 0.9× 2.1k 1.1× 3.5k 2.1× 2.7k 1.9× 1.7k 1.4× 252 10.2k

Countries citing papers authored by Edward E. Graves

Since Specialization
Citations

This map shows the geographic impact of Edward E. Graves's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward E. Graves with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward E. Graves more than expected).

Fields of papers citing papers by Edward E. Graves

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edward E. Graves. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward E. Graves. The network helps show where Edward E. Graves may publish in the future.

Co-authorship network of co-authors of Edward E. Graves

This figure shows the co-authorship network connecting the top 25 collaborators of Edward E. Graves. A scholar is included among the top collaborators of Edward E. Graves based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edward E. Graves. Edward E. Graves is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tadepalli, Sirimuvva, et al.. (2025). Radiation-Induced Immune Responses from the Tumor Microenvironment to Systemic Immunity. Cancers. 17(23). 3849–3849.
2.
Wang, Jinglong, Hongbin Cao, Stavros Melemenidis, et al.. (2025). FTO inhibition enhances the therapeutic index of radiation therapy in head and neck cancer. JCI Insight. 10(11). 3 indexed citations
3.
Melemenidis, Stavros, Vignesh Viswanathan, Suparna Dutt, et al.. (2025). Effectiveness of FLASH vs. Conventional Dose Rate Radiotherapy in a Model of Orthotopic, Murine Breast Cancer. Cancers. 17(7). 1095–1095. 1 indexed citations
4.
Tadepalli, Sirimuvva, Derek R. Clements, Rebeca Arroyo Hornero, et al.. (2023). Rapid recruitment and IFN-I–mediated activation of monocytes dictate focal radiotherapy efficacy. Science Immunology. 8(84). eadd7446–eadd7446. 14 indexed citations
5.
Benej, Martin, Jinghai Wu, Ioanna Papandreou, et al.. (2021). Pharmacological Regulation of Tumor Hypoxia in Model Murine Tumors and Spontaneous Canine Tumors. Cancers. 13(7). 1696–1696. 7 indexed citations
6.
Eke, Iris, Molykutty J. Aryankalayil, Veit Sandfort, et al.. (2021). Long-term expression changes of immune-related genes in prostate cancer after radiotherapy. Cancer Immunology Immunotherapy. 71(4). 839–850. 10 indexed citations
7.
Aguilera, Todd A., Eslam A. Elghonaimy, Hussein Shehade, et al.. (2020). Induced Tumor Heterogeneity Reveals Factors Informing Radiation and Immunotherapy Combinations. Clinical Cancer Research. 26(12). 2972–2985. 6 indexed citations
8.
Li, Albert M., Gregory S. Ducker, Yang Li, et al.. (2020). Metabolic Profiling Reveals a Dependency of Human Metastatic Breast Cancer on Mitochondrial Serine and One-Carbon Unit Metabolism. Molecular Cancer Research. 18(4). 599–611. 58 indexed citations
9.
Zheng, Xianchuang, et al.. (2019). A Near-Infrared Phosphorescent Nanoprobe Enables Quantitative, Longitudinal Imaging of Tumor Hypoxia Dynamics during Radiotherapy. Cancer Research. 79(18). 4787–4797. 22 indexed citations
10.
Eke, Iris, Dali Zong, Molykutty J. Aryankalayil, et al.. (2019). 53BP1/RIF1 signaling promotes cell survival after multifractionated radiotherapy. Nucleic Acids Research. 48(3). 1314–1326. 17 indexed citations
11.
Rafat, Marjan, Todd A. Aguilera, Marta Vilalta, et al.. (2018). Macrophages Promote Circulating Tumor Cell–Mediated Local Recurrence following Radiotherapy in Immunosuppressed Patients. Cancer Research. 78(15). 4241–4252. 38 indexed citations
12.
Chiou, Shin-Heng, Viviana I. Risca, Gordon Wang, et al.. (2017). BLIMP1 Induces Transient Metastatic Heterogeneity in Pancreatic Cancer. Cancer Discovery. 7(10). 1184–1199. 49 indexed citations
13.
Xiao, Nan, Hongbin Cao, Che‐Hong Chen, et al.. (2013). A Novel Aldehyde Dehydrogenase-3 Activator (Alda-89) Protects Submandibular Gland Function from Irradiation without Accelerating Tumor Growth. Clinical Cancer Research. 19(16). 4455–4464. 22 indexed citations
14.
Le, Quynh‐Thu, Richard Fisher, Kelly S. Oliner, et al.. (2012). Prognostic and Predictive Significance of Plasma HGF and IL-8 in a Phase III Trial of Chemoradiation with or without Tirapazamine in Locoregionally Advanced Head and Neck Cancer. Clinical Cancer Research. 18(6). 1798–1807. 41 indexed citations
15.
Nair, Viswam S., Olivier Gevaert, Guido Davidzon, et al.. (2012). Prognostic PET 18F-FDG Uptake Imaging Features Are Associated with Major Oncogenomic Alterations in Patients with Resected Non–Small Cell Lung Cancer. Cancer Research. 72(15). 3725–3734. 103 indexed citations
16.
Chan, Denise A., Patrick D. Sutphin, Phuong Nguyen, et al.. (2011). Targeting GLUT1 and the Warburg Effect in Renal Cell Carcinoma by Chemical Synthetic Lethality. Science Translational Medicine. 3(94). 94ra70–94ra70. 456 indexed citations
17.
Graves, Edward E., Marta Vilalta, Ivana Cecić, et al.. (2010). Hypoxia in Models of Lung Cancer: Implications for Targeted Therapeutics. Clinical Cancer Research. 16(19). 4843–4852. 63 indexed citations
18.
Cairns, Rob A., Kevin L. Bennewith, Edward E. Graves, et al.. (2009). Pharmacologically Increased Tumor Hypoxia Can Be Measured by 18F-Fluoroazomycin Arabinoside Positron Emission Tomography and Enhances Tumor Response to Hypoxic Cytotoxin PR-104. Clinical Cancer Research. 15(23). 7170–7174. 28 indexed citations
19.
Cheng, Zeneng, et al.. (2007). Small-Animal PET of Melanocortin 1 Receptor Expression Using a 18F-Labeled  -Melanocyte-Stimulating Hormone Analog. Journal of Nuclear Medicine. 48(6). 987–994. 63 indexed citations
20.
Ntziachristos, Vasilis, Eyk Schellenberger, Jorge Ripoll, et al.. (2004). Visualization of antitumor treatment by means of fluorescence molecular tomography with an annexin V–Cy5.5 conjugate. Proceedings of the National Academy of Sciences. 101(33). 12294–12299. 262 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026